| |
| |
|
| Insider
Information: |
Thiel Carsten |
| Relationship: |
EVP, Chief Commercial ... |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
33,860 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,179,450 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
33,860 |
|
|
| Total
Value |
$6,179,450 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
EVP, Chief Commercial ... |
2017-02-28 |
33,860 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2017-02-28 |
4 |
AS |
$131.01 |
$495,611 |
D/D |
(3,783) |
33,860 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2017-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
37,643 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2017-02-28 |
4 |
S |
$0.00 |
$0 |
D/D |
(54) |
30,143 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2017-02-27 |
4 |
S |
$131.20 |
$9,315 |
D/D |
(71) |
30,197 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2017-02-06 |
4 |
S |
$125.69 |
$20,739 |
D/D |
(165) |
30,268 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2016-12-09 |
4 |
AS |
$130.00 |
$300,040 |
D/D |
(2,308) |
30,433 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2016-10-14 |
4 |
AS |
$120.28 |
$551,364 |
D/D |
(4,584) |
32,741 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2016-10-03 |
4 |
S |
$122.41 |
$3,550 |
D/D |
(29) |
37,325 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2016-09-13 |
4 |
S |
$129.00 |
$387,000 |
D/D |
(3,000) |
37,354 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2016-09-12 |
4 |
S |
$124.20 |
$27,945 |
D/D |
(225) |
40,354 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2016-09-06 |
4 |
S |
$125.94 |
$125,940 |
D/D |
(1,000) |
40,579 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2016-02-29 |
4 |
S |
$138.91 |
$7,501 |
D/D |
(54) |
41,579 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2016-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
41,633 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2016-02-16 |
4 |
S |
$143.49 |
$26,833 |
D/D |
(187) |
36,633 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
8,802 |
36,820 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2015-11-10 |
4 |
S |
$173.34 |
$520,020 |
D/D |
(3,000) |
28,018 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2015-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
31,018 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, EMEA & Asia Pacific |
• – – |
2015-09-10 |
4 |
S |
$169.15 |
$137,371 |
D/D |
(812) |
29,018 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, EMEA & Asia Pacific |
• – – |
2015-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
3,830 |
29,830 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, EMEA & Asia PacificOffice |
• – – |
2015-02-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
26,000 |
|
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
